Ginkgo Bioworks Holdings Inc (DNA)
7.285
-1.32
(-15.29%)
USD |
NYSE |
Nov 14, 16:00
7.37
+0.08
(+1.17%)
After-Hours: 20:00
Ginkgo Bioworks Holdings Total Assets (Quarterly): 1.625B for June 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 1.625B |
| March 31, 2024 | 1.582B |
| December 31, 2023 | 1.665B |
| September 30, 2023 | 2.026B |
| June 30, 2023 | 2.292B |
| March 31, 2023 | 2.417B |
| December 31, 2022 | 2.539B |
| Date | Value |
|---|---|
| September 30, 2022 | 1.871B |
| June 30, 2022 | 1.994B |
| March 31, 2022 | 2.058B |
| December 31, 2021 | 2.071B |
| September 30, 2021 | 2.151B |
| December 31, 2020 | 675.15M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
675.15M
Minimum
Dec 2020
2.539B
Maximum
Dec 2022
1.921B
Average
2.026B
Median
Sep 2023
Total Assets (Quarterly) Benchmarks
| Boston Scientific Corp | 38.08B |
| UnitedHealth Group Inc | 299.31B |
| CEL-SCI Corp | 24.07M |
| AIM ImmunoTech Inc | 15.72M |
| IGC Pharma Inc | 10.59M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 792.18M |
| Shareholders Equity (Quarterly) | 833.07M |
| Current Ratio | 4.715 |